Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine

Clinical Infectious Diseases

Volumn 58, Issue 8, 2014, Pages 1125-1128

  Tseng, Hung Fu ^a   Schmid, D Scott ^b   Harpaz, Rafael ^b   Larussa, Philip ^c   Jensen, Nancy J ^b   Rivailler, Pierre ^b   Radford, Kay ^b   Folster, Jennifer ^b   Jacobsen, Steven J ^a  

^a KAISER PERMANENTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Department of Pediatrics College of Physicians and Surgeons Columbia University ^*  (United States)

Author keywords

adult vaccination; herpes zoster; varicella zoster virus

Indexed keywords

ACICLOVIR; PARACETAMOL; VARICELLA ZOSTER VACCINE; VIRUS DNA;

AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BASAL CELL; CASE REPORT; FEMALE; GENE SEQUENCE; HERPES ZOSTER; HOT FLUSH; HUMAN; HUMAN HERPES VIRUS 3 STRAIN OKA; IMMUNOCOMPETENCE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; RASH; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BURNING SENSATION; SKIN PAIN; VIRUS ISOLATION; VIRUS NOMENCLATURE; WILD TYPE; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PATHOLOGY; VARICELLA ZOSTER VIRUS; VIROLOGY; VIRUS GENOME;

AGED; DNA, VIRAL; FEMALE; GENOME, VIRAL; HERPES ZOSTER; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84897401835     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu058     Document Type: Article

References (16)

1. Weinmann S, Chun C, Schmid DS, et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis 2013; 208:1859-68.
2. Gershon AA, Chen J, Davis L, et al. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc 2012; 123:17-33; discussion 33-5.
3. Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008; 197(suppl 2):S165-9.
4. Argaw T, Cohen JI, Klutch M, et al. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J Infect Dis 2000; 181:1153-7.
5. LaRussa P. Experience with live-attenuated varicella-zoster vaccines. Contrib Microbiol 1999; 3:173-92.
6. Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol 2000; 38:3156-60.
7. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol 2000; 38:4315-9.
8. Breuer J, Grose C, Norberg P, Tipples G, Schmid DS. A proposal for a common nomenclature for viral clades that form the species varicellazoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. J Gen Virol 2010; 91:821-8.
9. Gomi Y, Sunamachi H, Mori Y, Nagaike K, Takahashi M, Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 2002; 76:11447-59.
10. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012; 7: e46688.
11. Sharrar RG, LaRussa P, Galea SA, et al. The postmarketing safety profile of varicella vaccine. Vaccine 2000; 19:916-23.
12. Kilgore PE, Kruszon-Moran D, Seward JF, et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 2003; 70(suppl 1):S111-8.
13. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84.
14. Langan SM, Smeeth L, Margolis DJ, Thomas SL. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med 2013; 10: e1001420.
15. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011; 305:160-6.
16. Depledge DP, Kundu S, Jensen N, et al. Deep sequencing of viral genomes provides insight into the pathogenesis of varicella-zoster virus and its vaccine in humans. Mol Biol Evol 2014; 31: 397-409.